MEGARIO-DHA
Omgea 3 Fatty Acid 500mg,EPA 250mg & DHA 185mg Suspension
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | MEGARIO-DHA |
| Active Formulation (Salt) | Omgea 3 Fatty Acid 500mg,EPA 250mg & DHA 185mg Suspension |
| Dosage Form | SYRUPS |
| Packaging Presentation | 150ml |
| Therapeutic Category | SYRUPS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is MEGARIO-DHA?
Therapeutic monograph and clinical profile
MEGARIO-DHA (Omgea 3 Fatty Acid 500mg,EPA 250mg & DHA 185mg Suspension) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 150ml, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Cardiovascular Support / Cognitive & Brain Function.
Key Formulation Highlights
Why healthcare professionals recommend MEGARIO-DHA
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Cardiovascular Support / Cognitive & Brain Function
Pharmacological Mechanism of Action
How MEGARIO-DHA acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for MEGARIO-DHA
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for MEGARIO-DHA across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding MEGARIO-DHA
What is MEGARIO-DHA used for?
What is the printed packaging and MRP of MEGARIO-DHA?
How can I get monopoly PCD franchise for MEGARIO-DHA?
Related Formulations in SYRUPS
Explore complementary WHO-GMP certified healthcare formulations
